Citius pharmaceuticals to feature updated positive interim results of i-msc study during poster presentation at international society for cell and gene therapy

Cranford, n.j., may 18, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that it will present a poster at the international society for cell and gene therapy (isct) annual meeting, to be held virtually may 26-28, 2021.
CTXR Ratings Summary
CTXR Quant Ranking